Integrating Image-Based High-Content Screening with Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective

Li-Hsien Chen1, Yuan-Ting Sun2, Yih-Fung Chen3

  • 1Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Insights

This study identified 5-hydroxydecanoate (5-HD) as a potential neuroprotective drug against chemotherapy-induced neurotoxicity. 5-HD effectively protected neurons and alleviated symptoms in mice without compromising cancer treatment efficacy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Oncology

Background:

  • Chemotherapy-induced neurotoxicity is a significant challenge in cancer care.
  • Current treatments lack effective neuroprotective agents.
  • Paclitaxel-induced neurotoxicity affects neuronal function and patient quality of life.

Purpose of the Study:

  • To discover novel neuroprotective drugs for paclitaxel-induced neurotoxicity.
  • To establish and validate an image-based high-content screening platform for neuroprotection.
  • To investigate the therapeutic potential of 5-hydroxydecanoate (5-HD).

Main Methods:

  • Developed an image-based high-content screening platform for neuronal viability, neurite outgrowth, and synaptogenesis.
  • Screened compound libraries including ion channel ligands, REDOX, and GABAergic ligands.
  • Validated 5-HD's efficacy in vitro (cortical and DRG neurons) and in vivo (mouse behavioral tests and sciatic nerve analysis).
  • Investigated the mechanism involving intracellular calcium homeostasis.
  • Assessed 5-HD's impact on paclitaxel's antitumor effect in xenograft models.

Main Results:

  • 5-hydroxydecanoate (5-HD) demonstrated significant neuroprotective effects against paclitaxel-induced neurotoxicity in neuronal cultures.
  • In vivo studies showed 5-HD restored thermal sensitivity and alleviated mechanical allodynia in paclitaxel-treated mice.
  • 5-HD reduced sciatic nerve damage and normalized intracellular calcium dysregulation.
  • Crucially, 5-HD did not interfere with paclitaxel's anticancer activity.

Conclusions:

  • An effective image-based high-content screening platform for neuroprotection was established.
  • 5-hydroxydecanoate (5-HD) is identified as a promising therapeutic agent for paclitaxel-induced neuropathy.
  • 5-HD offers a potential strategy to mitigate chemotherapy side effects without compromising treatment efficacy.